Genetic risk scores (GRSs) are weighted sums of risk allele counts of single nucleotide polymorphisms (SNPs) associated with a disease or trait. Construction of GRSs is typically based on published results from Genome-Wide Association Studies (GWASs), the majority of which have been performed in large populations of European ancestry (EA) individuals. While many genotype-trait associations have been shown to generalize from EA populations to other populations, such as Hispanics/Latinos, the optimal choice of SNPs and weights for GRSs may differ between populations due to different linkage disequilibrium (LD) and allele frequency patterns. This is further complicated by the fact that different Hispanic/Latino populations may have different admixture patterns, so that LD and allele frequency patterns may not be the same among non-EA populations. Here, we compare various approaches for GRS construction, using GWAS results from both large EA studies and a smaller study in Hispanics/Latinos, the * Correspondence: tsofer@bwh.harvard.edu Hispanic Community Health Study/Study of Latinos (HCHS/SOL, n = 12, 803). We consider multiple ways to select SNPs from association regions and to calculate the SNP weights. We study the performance of the resulting GRSs in an independent study of Hispanics/Latinos from the Woman Health Initiative (WHI, n = 3, 582). We support our investigation with simulation studies of potential genetic architectures in a single locus. We observed that selecting variants based on EA GWASs generally performs well, as long as SNP weights are calculated using Hispanics/Latinos GWASs, or using the meta-analysis of EA and Hispanics/Latinos GWASs. The optimal approach depends on the genetic architecture of the trait.
Introduction
Genetic Risk Scores (GRSs) summarize the genetic component of a disease or quantitative (continuous) trait and are typically constructed as the weighted sum of risk alleles of single nucleotide polymorphisms (SNPs) associated with the trait of interest. GRSs are routinely used in public health genetics research for a wide range of applications, such as improving disease and trait prediction; 1 studying the shared genetic basis between traits; 2 increasing power by integrating over multiple variants rather than one variant at a time; and Mendelian Randomization studies, 3, 4 in which a GRS associated with one trait is used as an instrumental variable in a causal analysis of the association of the trait with another outcome. SNPs and weights used to construct GRSs are usually selected based on findings from published studies, such as Genome-Wide Association Studies (GWASs). 5 However, most GWASs to date have been performed in studies of individuals of exclusively or predominantly European genetic ancestry (EA). This poses a difficulty for GRS construction in non-EA populations.
Using EA GWAS to select SNPs and choose weights for GRSs in non-EA populations seems like a reasonable approach, in particular, Hispanics/Latinos are admixed with European ancestry, and previous studies have shown that many EA GWAS results generalize to Hispanics/Latinos. 7, 9 . Furthernore, the EA GWASs are very large (with tens or hundreds of thousands of individuals), therefore having large statistical power to detect the most strongly associated variants from genomic association regions and obtain precise estimates of effects sizes. In fact, Dudbridge (2013) 6 studied power and prediction accuracy of GRSs and suggested that, for prediction (rather than association testing), hundreds of thousands of subjects may be needed to estimate SNP effects.
While such numbers are available in EA GWASs, they are not currently available in GWASs of diverse populations such as Hispanics/Latinos. For example, in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a large cohort study of Hispanics/Latinos, there are fewer than 13,000 individuals who consented for genetic studies. Of these, about 7,000 individuals participated in a GWAS of diabetes, 7 which is the largest published GWAS to date in Hispanics/Latinos.
In contrast, the largest published GWAS of diabetes 8 meta-analyzed multiple studies of European ancestry (N =∼70,000 cases and controls), and a smaller number of population studies of other ancestries (including about 2,500 Mexicans).
There are a number of drawbacks to using EA GWAS for GRS construction in non-EA populations. Specifically, linkage disequilibrium (LD) patterns vary across populations, 10 rendering different best available tag SNPs between populations; allele frequencies often differ across populations; and, at least for some traits, effect sizes differ between populations and allelic heterogeneity exists. 11 Admixed populations, such as Hispanics/Latinos, may have different genetic architecture and effect sizes at a genetic association region compared to an ancestral population due to genegene (epistasis) or gene-environment interactions, or because a causal variant monomorphic in one ancestral population. 11, 7 For example, Belsky et al. (2013) 12 constructed a GRS for obesity based on EA GWAS results, and found that its utility for an African American (AA) population was low, and much lower than that for an EA population. Martin et. al. (2017) 13 studied transferability of GRSs constructed based on single-ancestry GWASs to other ancestries, and demonstrated that scores inferred from EA GWASs may perform poorly in other ancestries. Collectively, these studies highlight the need to adapt GRSs construction methods to diverse ancestries.
How to best construct a GRS for a study in a Hispanic/Latino population is still an open question. Should one use only the information published in a large, primarily EA study? or can we use results from a smaller, non-EA study? In particular, will incorporating information from these lower-powered (smaller sample size) non-EA GWAS in fact improve GRS construction, or will it instead introduce harmful variability? Here, we take a systematic, empirical approach to constructing GRSs for Hispanics/Latinos, based on GWAS results from large population studies of European ancestry and medium-sized studies of Hispanics/Latinos. We use published EA GWASs results and GWAS findings from the HCHS/SOL to construct and evaluate GRSs in an independent study of Hispanic/Latina women from the Women Health Initiative (WHI). We support our results with simulations mimicking potential genetic architecture within a single, trait-associated genomic region.
Materials and Methods
Let y i be a quantitative trait measured on the ith participant, i = 1, . . . , n, and x i a k × 1 vector of covariates such as confounders. Let g 1i , . . . , g P i be allelic counts or dosages of P independent variants associated with y i , and α 1 , . . . , α P their effect sizes, so that the additive linear model holds:
where i are residual errors. An optimal GRS for y i is G opt i = P p=1 g pi α p , the weighted sum with the causal genotypes and their true effects.
Issues in selection of SNPs for GRS
In reality, we do not know which are the true causal genotypes for a trait, so we have to select a set of SNPs to use in our GRS. Often, the data we have at our disposal for selecting SNPs are derived from a genotyping platform that did not interrogate all sequence genotypes, but rather a reduced set of a few million (or fewer) variants. For GRS construction, we often have only a set of associated genotypes that likely tag a subset of the causal genotypes.
Let g p be a causal genotype in populations of European ancestry, and let g p be a tag SNP to g p that was detected in an association study, perhaps because g p was not genotyped at all. It is well known 14 that the size of trait association at g p is related to the LD of g p with g p , denoted by ρ p , so that α p = ρ p α p . Given a large enough data set, we expect that the lead variant (the variant with strongest association in the region) will be the one with |ρ p | closest to the maximal value 1, among all available (genotyped or imputed) variants.
Further complicating this situation is the fact that tag SNPs may differ across populations. Assume the simple scenario of a single causal SNP in an association region, two ancestral populations P 1 and P 2 , the same effect size in all populations. Also, assume that in the admixed population g g t1 g t2
? Figure 1 : Tag SNPs likely have different linkage disequilibrium patterns with the causal SNP g in populations P 1 and P 2 , so that different observed tag SNPs may have stronger associations with the trait in the two populations. In the admixed population (ADM), the associations at the the tag SNPs depend on a, the proportions of chromosomes with this genomic regions inherited from the two ancestral populations.
(ADM) the proportion of genomic intervals containing the causal variant inherited from populations P 1 and P 2 is a and (1 − a), respectively. This is demonstrated in Figure 1 , which shows that even if the same tag SNPs were available in the two ancestral populations P 1 and P 2 , and we knew which tag SNPs were the best in each population, it is not clear which is the best tag SNP in ADM. This becomes even more complicated when there are multiple ancestral populations, when SNP availability differs due to different genotyping platforms, and when effect sizes differ between ancestral populations.
In simulations studies, we investigated the impact of genetic architecture by focusing on a single genomic region at a time, while in data analysis we considered the overall results of systematic genome-wide approaches for GRS construction. We created lists of candidate SNPs for GRSs by filtering variants based on these measures (p e , p h , p m , r m ) and with varying thresholds. We considered the p-value thresholds 5 × 10 −8 , 1 ×
For generalization analysis, we initially took all variants with p-value < 10 −6 in the EA GWAS, then performed generalization analysis using these SNPs to compute r-values. Therefore, by construction, smaller lists of SNPs are considered using this approach.
After subsetting the list of available SNPs by the selection criteria (e.g., all SNPs with p-value smaller than 10 −6 computed in the EA GWAS, all SNPs with p-value smaller than 5 × 10 −8 in the meta-analysis GWAS, etc.) to generate a list of candidate SNPs, we further pruned the list to keep only the lead SNP from every genomic region of 1Mbp. The first lead SNP is defined as the most significant SNP in the list; then, all SNPs in the 1Mbp region centered at this SNP are removed from the list of candidate SNPs. We continued this process of identifying the next lead SNP and removing SNPs in its proximity until no SNP remained. We also considered another method for selecting SNPs, which we call "matched SOL". For this approach, we took the list of lead SNPs from the EA GWAS, and searched for the lead HCHS/SOL SNP among the common (MAF≥ 0.05)
genotyped SNPs within 1Mbp around it.
In simulation studies, where we focus on a single association region, we did not filter variants.
Instead, we selected only a single lead SNP from the region based on the same criteria described above (lead EA, lead in meta-analysis, etc.).
SNP weights. The optimal GRS weights reflect the true size of association between each SNP in the GRS and the trait. In practice, the size of this association must be estimated. We considered the effect size estimates computed in the EA GWAS, which may be very accurate in the EA pop-ulation but potentially less appropriate in the admixed population due to different LD patterns in the two populations. Therefore, we also considered the effect size estimated in an admixed population (HCHS/SOL in the data analysis) and the effect size estimated in fixed effects meta-analysis.
We also compared these to no weights (or α p = 1 ∀p) because unweighted GRS are often used in practice. 7, 2 Evaluating the GRS. To evaluate GRS approaches, we constructed GRSs in an independent validation data set based on SNP selection and weights computed in the training data set. In simulations, we used a validation data set with different admixture patterns than the training data set, to reflect the fact that different admixed populations often differ to some extent in their admixture patterns. In our data analysis, the training data set was HCHS/SOL and the validation data set was the WHI SNP Health Association Resource (SHARe) Hispanic/Latina women.
Let the GRS for participant i in the validation data set be
where S is the selected set of SNPs (which is likely different than the true causal set S, and in the simulation has a single SNP only), and α j is the estimated effect of the jth SNP is the set.
We considered two measures for evaluation. For simulation studies we used the Mean Squared Prediction Error (MSPE), computed by
across the n v individuals in the validation data set, where we report the squared root of the MSPE (RMSPE). In data analysis, we computed the variance explained by each GRS in a regression model adjusted for sex, age, and the first five principal components (PCs) of genetic ancestry. This was calculated by first fitting a model with these covariates, but without the GRS, and obtaining the residual variance denoted by σ 2 0 , then fitting a model that also included the GRS and obtaining the residual variance σ 2 g . The estimated percent variance explained is 100
Simulation study
Our simulation studies focused on the impact of LD and variability in the estimation of effect sizes (due to sample size and admixture) on GRSs. We simulated genotypes in a 1Mbp genomic region for a large European sample (n EA = 50, 000), a moderately sized admixed sample (n ADM 12 = 12, 000), and a small admixed sample (n ADM 5 = 5, 000). ADM 12 
Evaluating similarity between LD patters
We evaluated the similarity between LD patterns of the simulated populations CEU, ADM Using the HCHS/SOL to develop Hispanic/Latino specific GRSs
Previously published EA GWASs and traits
We considered three groups of traits with previously published GWAS results: anthropometric, comprising of height, body mass index (BMI), hip circumference (HIP), waste circumference (WC), and waste-to-hip ratio (WHR) from the GIANT consortium GWAS; 18-20 blood pressure traits, comprising of systolic and diastolic blood pressure (SBP, DBP), pulse pressure (PP = SBP-DBP), and mean arterial pressure (MAP=DBP+1/3PP), with GWASs performed by the International
Consortium of Blood Pressure (ICBP) 21, 22 ; and finally, blood count traits, including white blood cell count (WBC), platelet count (PLT), and hemoglobin count (HGB). [23] [24] [25] Note that for these blood count GWASs, we used just the EA GWAS results and not the trans-ancestry results that were also available.
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
The HCHS/SOL is a community-based cohort study following 16 
Results

Simulations
Our simulations focused on a single, 1Mbp genomic region, which contains 617 SNPs. We first evaluated the similarity of LD patterns between potential reference populations (CEU, ADM training data set) and the test data set, and then evaluated the combined impact of LD, genetic architecture, and variability in effect estimates on GRS performance.
LD patterns in the admixed samples are more similar to each other than to CEU in the ADM training data is sometimes advantageous over EA weights. However, this was true only when ADM 12,0.2 was the training data set, but not when ADM 12,0.4 was the training data set.
Performance of GRSs in the simulated test data sets
Other than that, both EA and META SNP selections and weights constructions usually performed similarly, with a few more settings in which META weights outperformed EA weights. We do note that all types of GRS suffered from outlying scenarios: specific combinations of causal SNP(s) in which one GRS produced extremely large RMSPEs. However, on average we see better performance of GRSs based on the META and EA GWAS relative to the other two selection approaches when the causal SNPs' effect sizes are the same across populations.
Performance of GRSs in the Women's Health Initiative data set
We constructed GRSs for 3,642 Hispanic/Latina women from the WHI based on EA GWAS, HCHS/SOL GWAS, and combinations of the two for each of 12 traits. The results differed considerably across families of traits (anthropometric, blood count, and blood pressure), so we focus on each separately. Figures comparing the percent of variance explained by each GRS for each trait are provided in the Supplementary Information. Here, Figure 3 illustrates the patterns observed in each trait family by comparing the variance explained by GRSs for one trait from each family (BMI, HGB, and MAP). Figure 3 compares the performance of GRSs that selected SNPs based on EA GWAS, but with various choices of p-value thresholds and weights.
In general, our data analysis demonstrates that selecting variants for the GRS based on association results in the EA GWAS performs well, in agreement with the simulation results. The best choice of weights is usually estimated effect sizes from the HCHS/SOL GWAS or from the metaanalysis of the EA and HCHS/SOL GWASs (META). We now summarize the results by families of traits.
Anthropometric traits
We considered five anthropometric traits: height, BMI, WC, WHR and HIP. Across all traits in this family, selecting SNPs using the EA GWAS or META performed similarly well, except in the case of WHR where selection based on EA has the slight advantage. The best choice of weights was also the same across all anthropometric traits, with weights from the EA GWAS and the meta-analysis GWAS performing similarly well. Optimal p-value thresholds for selecting SNPs differed across traits: for BMI, HIP, WC, and WHR the highest performing GRSs usually started from the list of SNPs with p-value< 10 −3 , while for height the optimal threshold was 10 −5 − 10 −6 . The best performing GRSs explained about 10% of the variance of height in the WHI, 3% of the variance of BMI and HIP, 2.5% for WC, and less than 2% for WHR.
Blood count traits
For blood count traits (PLT, WBC, HGB), the best performing GRSs were constructed either by selecting SNPs with EA GWAS, or META, p-values< 10 −5 − 10 −3 (optimal threshold varied by trait). For two traits (HGB and PLT), SNP selection using generalization also performed very well.
The best performing weights were either the estimated effect sizes from HCHS/SOL (PLT, WBC) or META (HGB). Variance explained for the best GRSs ranged from ∼1.3% (HGB) to 4% (PLT).
Blood pressure traits
In contrast to the other trait families, for blood pressur traits (SBP, DBP, PP, MAP) selection of variants using the EA GWAS results performed poorly-unless weights were the effect size estimates from the HCHS/SOL GWAS, in which case the GRSs performed very well in comparison to other options. On the other hand, when selecting variants according to META, the GRS performance was robust to the choice of weights. Still, overall the GRSs that explained the highest percentage of variance used HCHS/SOL-based weights. An exception was the trait PP, for which selecting lead SNPs based on generalization analysis performed best, and was not sensitive at all to weight computation. However, the total percent of variance of PP explained by the best GRS was quite low: 0.4%. In comparison, the BP trait with the highest percent of variance explained by a GRS was MAP (1% explained by the best GRS). The optimal p-value threshold for SNP selection varied among traits and selection approaches.
Discussion
We studied several approaches for constructing GRSs in Hispanic/Latino populations, using GWAS results from independent studies in large populations of European ancestry (EA) and mediumsized GWASs in Hispanics/Latinos. We studied the performance of GRSs constructed using these approaches on an independent data set. Results differed by trait. For anthropometric traits, the best strategies for both selecting variants for the GRS and for computing weights were based on either the EA GWAS or the meta-analysis of GWAS results from EA and HCHS/SOL, with a slight, but possibly negligible, advantage to selection based on meta-analysis results. For blood count traits (hemoglobin, white blood cell, and platelet counts), there was a slight advantage for selecting SNPs based on meta-analysis results, and it was generally preferable to use weights based on the HCHS/SOL GWAS. For blood pressure traits (SBP, DBP, MAP and PP), the best strategy overall was to select SNPs using the EA GWAS results and use weights from the HCHS/SOL GWAS, although the GRSs were more robust to different calculations of weights when meta-analysis results were used to select SNPs.
Our simulation studies were performed in simplified scenarios in which the effect sizes were the same in both ancestries, and in the admixed populations themselves. The LD patterns between two admixed populations with different admixture proportions were more similar to each other than the LD patterns between an admixed population and the simulated EA population, and further, LD estimates were very precise, with the same r 2 observed when using 5,000 or more individuals for estimation. Therefore, given large enough sample size we expect that one admixed population will be a better reference for GRS construction in another admixed population compared to an EA population, and these simulations demonstrate how sample sizes used in the reference GWAS impact consequent GRS construction under various genetic architecture settings. In simulation results, usually the GRSs with SNP selection using EA GWAS and weights using META performed best, and weights using the admixed training data sets usually performed poorly. This results is supported by other work 6 that suggested that many thousands of individuals are required to effectively calculate effect sizes to be used as SNP weights.
In the data analysis, however, in some cases GRSs weighted by the HCHS/SOL GWAS where superior to other weights. One possible explanation to the improved performance of the HCHS/SOL weights in data analysis is a strong signal-to-noise ratio for some traits and SNPs. Another possible reason is that the simplifying assumptions of the simulations do not hold and for some traits the SNP effect sizes differ by ancestry, or by population (e.g. due to gene-environment interaction).
Thus, if the EA weights are inadequate despite the large sample size, it suggests that the estimates themselves are not appropriate for the admixed population. This is in agreement with the work of Coram et al., 36 who assumed different effect sizes between populations, and found that estimating effect for risk prediction purposes is useful in ethnically-matched population, while SNP selection using EA GWAS is generally appropriate.
Our study has a few limitations. First, we looked only at the performance of GRSs in independent validation data sets, so our results do not inform the construction of GRSs to be used in the same study (e.g., a Mendelian Randomization study). Furthermore, the independent validation study in our data analysis, WHI, only includes female participants, while our training studies, EA GWAS results and the HCHS/SOL, included both males and females. As gene-sex interactions likely exist, the GRSs constructed using the general population may not be optimal for women.
However, this is unlikely to introduce any systematic biases to the SNP selection and SNP weights calculation procedures, so the relative performance of the GRS construction approaches should not be impacted. We did not investigate the entire literature for each trait and then investigate each of those loci separately, as is sometimes done in practice, but instead applied the same algorithm to each trait, based on two reference GWASs. While the first approach is useful for investigators who work with a single GRS and want to optimize it, it is also more case-dependent, and less generalizable. Our systematic approach is easier to apply on a number of traits and is appropriate for drawing general conclusions. Finally, we did not use multi-ethnic GWASs for GRS construction, but rather focused on EA and and Hispanic/Latino GWASs. Our goal was to more clearly delineate properties of the genetic architecture similarities or differences between populations. Another limitation of the current study is the lack of systematic investigation into generalizability of our results to other types of populations and varying sample sizes. It is a topic of future research as results from larger diverse studies become available. In the Supplementary Information, we report the results of a secondary analysis repeating the same data analysis reported in the manuscript, while evaluating GRSs on WHI African American women. Interestingly, the pattern of results is generally similar. This suggest that leveraging trans-ethnic information into GRS construction is beneficial.
Other recent methodological work on GRSs has been performed primarily in the context of 38 proposed LDpred for incorporating information from GWAS summary statistics and a reference panel to use information from multiple SNPs, rather than only the lead SNP, from an association region. While they demonstrated this method to be useful under specific priors for genetic architecture, their approach hinges on having a good reference panel.
Different admixed populations differ in their admixture patterns, so the same reference panel may not be appropriate across the board. It will be interesting to study and potentially extend this 38 approach to admixed populations, despite the lack of training and testing samples with the same LD structure.
Supplemental Data
The Supplemental Data includes detailed information about the simulation studies and figures with results from simulations, and figures comparing performances of all GRSs of all investigated traits in the WHI Hispanics, as well in the WHI African American (secondary analysis).
